Eam Global Investors LLC Dyne Therapeutics, Inc. Transaction History
Eam Global Investors LLC
- $402 Million
- Q2 2024
A detailed history of Eam Global Investors LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Eam Global Investors LLC holds 127,247 shares of DYN stock, worth $3.85 Million. This represents 1.12% of its overall portfolio holdings.
Number of Shares
127,247Holding current value
$3.85 Million% of portfolio
1.12%Shares
1 transactions
Others Institutions Holding DYN
# of Institutions
202Shares Held
105MCall Options Held
82.7KPut Options Held
24.8K-
Atlas Venture Life Science Advisors, LLC8.02MShares$242 Million37.7% of portfolio
-
Fcpm Iii Services B.V. Naarden, P77.85MShares$237 Million40.83% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$223 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.39MShares$193 Million3.76% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.05MShares$183 Million3.22% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.56B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...